drugset / Trial / NCT02057380
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to provide access to continued treatment for subjects who participated in other Astellas sponsored trials and for whom the investigator feels the subject may benefit from continued treatment.
Timeline
- Start
- 2014-04-16
- Primary completion
- 2016-10-14
- Completion
- 2016-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erlotinib | Small molecule | — | Oral |
| Subject | Paclitaxel | Small molecule | — | Intravenous |
| Subject | linsitinib | Small molecule | — | Oral |
| Background | Bortezomib | Small molecule | — | Subcutaneous |
| Background | Dexamethasone | Small molecule | — | Intravenous |